ADAR and melanoma: Interestingly, they also showed that edited peptide-specific tumor-infiltrating lymphocytes (TILs) infiltrate and kill melanoma tumor cells in vivo, suggesting that ADAR1 could have dual roles as an oncogene, and indirectly, promote TIL-specific tumor cell destruction [39].